Globally, cardiovascular disease (CVD) continues to be a leading cause of death in men and women alike.
According to the World Health Organization, CVD claims almost 18 million lives each year, making it the leading cause of global deaths at almost a third.
This cements cardiovascular health as a significant and highly pressing public health challenge.
The underlying risk pathways and clinical presentations, however, can vary between sexes.
For formulators developing the next generation of cardiovascular health-supporting nutraceuticals, reducing risk biomarkers is crucial.
At the same time, supporting the wider pathways that influence cardiovascular health is also beneficial.
Pairing clinically validated probiotics as the core driver, with targeted supporting ingredients, can offer more holistic preventive solutions for either men or women.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.